Home » Topics » BioWorld Science

BioWorld Science
RSS

Antiplatelet effects of policosanol, aspirin and policosanol + aspirin in humans

Jan. 5, 1998

Synaptic, Merck & Co. extend BPH research agreement

Jan. 5, 1998

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Jan. 5, 1998

Oral ganciclovir tested for prevention of CMV disease in transplant recipients

Jan. 5, 1998

MMP inhibitor developed at Chiroscience enters clinical trials for cancer

Jan. 5, 1998

Abelcet now approved in 18 countries

Jan. 5, 1998

Enrollment complete in pivotal trial of P829 for lung cancer imaging

Jan. 5, 1998

Antifungal agents prepared at Pola

Jan. 5, 1998

NOS inhibitors prepared at Ono

Jan. 5, 1998

Antiamnesic compounds described by Gedeon Richter

Jan. 5, 1998

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...